Molecular Testing for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the CAP/IASLC/AMP Guideline
- MeSH Terms
- Neoplasms (C04); Lung Neoplasms (C04.588.894.797.520)
- Guideline Contact
- guidelines@asco.org
- Publication Date
- 05-Feb-18
- Publication Scope
- assessment
- screening
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- ASCO (US)
- Publication Year
- 2018